Expression Levels of <i>TEL</i>, <i>AML1</i>, and the Fusion Products <i>TEL-AML1</i> and <i>AML1-TEL</i> versus Drug Sensitivity and Clinical Outcome in t(12;21)-Positive Pediatric Acute Lymphoblastic Leukemia - Concepedia

Concepedia

Publication | Open Access

Expression Levels of <i>TEL</i>, <i>AML1</i>, and the Fusion Products <i>TEL-AML1</i> and <i>AML1-TEL</i> versus Drug Sensitivity and Clinical Outcome in t(12;21)-Positive Pediatric Acute Lymphoblastic Leukemia

DOI Full Paper Access

26

Citations

28

References

2005

Year

W A G Stams, Monique L. den Boer, H. Berna Beverloo, Jules P.P. Meijerink, Elisabeth R. van Wering, Gritta Janka‐Schaub, Rob Pieters

Clinical Cancer Research

Abstract

High AML1-TEL expression is an independent poor prognostic factor in t(12;21)+ childhood ALL.

References

	Year	Citations

Page 1